CAS 1330037-21-2 N-Isovalerylglycine-[d9]

General Information
Catalog: BLP-009958
CAS: 1330037-21-2
Molecular Formula: C7H4D9NO3
Molecular Weight: 168.24

General Information

Catalog: BLP-009958

CAS: 1330037-21-2

Molecular Formula: C7H4D9NO3

Molecular Weight: 168.24

Chemical Structure

Description	N-Isovalerylglycine-[d9] is a labelled N-Isovalerylglycine. N-Isovalerylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. N-Isovalerylglycine is an intermediate product of the catabolism of leucine.
Synonyms	Isovalerylaminoacetic Acid-d9; N-(3-Methylbutyryl-d9)glycine
IUPAC Name	2-[[2,2,3,4,4,4-hexadeuterio-3-(trideuteriomethyl)butanoyl]amino]acetic acid
Related CAS	16284-60-9 (unlabelled)
Canonical SMILES	CC(C)CC(=O)NCC(=O)O
InChI	InChI=1S/C7H13NO3/c1-5(2)3-6(9)8-4-7(10)11/h5H,3-4H2,1-2H3,(H,8,9)(H,10,11)/i1D3,2D3,3D2,5D
InChI Key	ZRQXMKMBBMNNQC-APXHDBETSA-N
Purity	95% by HPLC; 98% atom D

N-Isovalerylglycine-[d9] is an isotopically labeled compound used in various scientific and medical research applications. Here are some key applications of N-Isovalerylglycine-[d9]:

Metabolic Research: N-Isovalerylglycine-[d9] is utilized as a tracer in metabolic studies to investigate metabolic pathways and fluxes. By incorporating this labeled compound, researchers can track its distribution and transformation within the body. This helps in understanding metabolic disorders and optimizing metabolic engineering strategies.

Pharmacokinetics: N-Isovalerylglycine-[d9] can be employed in pharmacokinetic studies to understand the absorption, distribution, metabolism, and excretion (ADME) of drugs. By using this labeled compound, researchers can gain insights into drug behavior and bioavailability. This information is vital for drug development and optimization.

Biochemical Pathway Elucidation: Researchers use N-Isovalerylglycine-[d9] to delve into biochemical pathways involving branched-chain amino acids and their derivatives. By examining how this compound is metabolized, scientists can uncover new information about enzyme functions and regulatory mechanisms. This knowledge is essential for developing targeted therapies for metabolic disorders.